Geom Therapeutics Overview

  • Founded
  • 2016
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Geom Therapeutics General Information


Developer of novel antibiotics designed to provide broad-spectrum coverage including activity against multi-drug resistants. The company's antibiotics provide superior survival to ceftazidime and doripenem in resistant aeruginosa systemic infection model, thereby enabling patients to get treated with multidrug-resistant gram-negative infections.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 826A Vallejo Street
  • San Francisco, CA 94133
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Geom Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 10-Mar-2020 00.000 Completed Out of Business
2. Early Stage VC (Series A) 08-Apr-2017 00.000 00.000 Completed Generating Revenue
1. Merger/Acquisition 07-Jul-2016 Completed Startup
To view Geom Therapeutics’s complete valuation and funding history, request access »